College of Pharmacy
In this section
Podcast Archive
Test - April 9, Try #2
Date posted: April 9, 2025, 2:19 pm
This is a test. Please disregard.
Test - April 9th
Date posted: April 9, 2025, 10:21 am
This is a test
test - after composer update
Date posted: March 27, 2024, 8:46 am
composer
Test - mailchimp
Date posted: March 27, 2024, 8:36 am
Testing
HelixTalk #157 - Everything Will Be ao-K+: Potassium Formulations and Dosing for Hypokalemia
Date posted: November 29, 2022, 6:00 am
In this episode, we review the management of a patient with hypokalemia, including both inpatient and outpatient supplementation with potassium chloride supplements and what dosage forms are available for potassium repletion.
HelixTalk #156 - There Is an App for That: Digital Health Advancements and More!
Date posted: November 8, 2022, 6:00 am
In this episode, we will define Digital Health, its categories and examples, describe how pharmacists are involved in DH practice, opportunities and limitations and future of DH. We will also discuss what implications DH has for educators, educational institutions, student pharmacists, pharmacists, and practice of pharmacy in general.
HelixTalk #155 - Oncology 911: Tumor Lysis Syndrome as an Oncologic Emergency
Date posted: October 18, 2022, 6:00 am
In this episode, we invite Dr. Amir Ali, PharmD, BCOP to discuss with us the pathophysiology, risk factors, prevention, and treatment clinical pearls of tumor lysis syndrome TLS).
HelixTalk #154 - What’s New With Paxlovid: Drug Interactions, Pharmacist Prescribing, “Paxlovid Mouth”, and a Brief Drug Review
Date posted: September 27, 2022, 6:00 am
In this episode, we review Paxlovid (nirmatrelvir/ritonavir) from the perspective of its pharmacology, efficacy, safety, pharmacists’ authority to prescribe, drug interactions, and rebound symptoms after Paxlovid therapy.
HelixTalk #153 - Buy One Get One Free: Learning All about the Dual Acting GIP and GLP-1 Receptor Agonist
Date posted: September 6, 2022, 6:00 am
In this episode, we will discuss mechanism, pharmacokinetics, efficacy, safety, and possible place in therapy for tirzepatide (Mounjaro), a new treatment for type 2 diabetes.
HelixTalk #152 - Strain-ger Things: Pneumococcal Vaccine Updates
Date posted: August 16, 2022, 6:00 am
In this episode, we will discuss the rationale behind the FDA approval of two new pneumococcal conjugate vaccines (PCV20 and PCV15), the characteristics of these vaccines, their place in therapy as recommended by the ACIP, and subsequent CDC immunization schedule changes.